VRCA
Verrica Pharmaceuticals
$3.42
−$0.06 (−1.72%)Oct 29, 2026
Key metrics
The numbers that frame VRCA today
- Market cap
- $58.75M
- Gross margin
- 85.9%
- EV / Sales
- 1.6
- ROIC
- -301.6%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $3.28
- 52wk High
- $9.82
Growth
Revenue and earnings trend for VRCA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VRCA
Is Verrica Pharmaceuticals a good buy?
No. Verrica Pharmaceuticals has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Verrica Pharmaceuticals is selling at a very high price.
What is the market capitalization of VRCA?
Verrica Pharmaceuticals's market capitalization is $58.75M.
What is the 52-week high for VRCA stock?
The 52-week high for Verrica Pharmaceuticals is $9.82. The current close of $3.42 is 65.2% below that high.
What is the 52-week low for VRCA stock?
The 52-week low for Verrica Pharmaceuticals is $3.28. The current close of $3.42 is 4.3% above that low.
Does VRCA stock pay dividends?
Verrica Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VRCA?
Verrica Pharmaceuticals's Debt / Equity ratio is 0.42.